» Journals » Int Rev Cell Mol Biol

International Review of Cell and Molecular Biology

The International Review of Cell and Molecular Biology is a prestigious journal that publishes cutting-edge research articles and reviews in the field of cell and molecular biology. It covers a wide range of topics including cell structure and function, molecular genetics, signal transduction, and cellular processes. With its rigorous peer-review process, the journal provides a platform for scientists and researchers to share their latest discoveries and advancements in this rapidly evolving field.

Details
Abbr. Int Rev Cell Mol Biol
Publisher Elsevier
Start 2008
End Continuing
p-ISSN 1937-6448
Country Netherlands
Language English
Recent Articles
1.
Galluzzi L, Spada S
Int Rev Cell Mol Biol . 2025 Feb; 391:xiii-xvii. PMID: 39939080
No abstract available.
2.
Ratre P, Thareja S, Mishra P
Int Rev Cell Mol Biol . 2025 Feb; 391:95-134. PMID: 39939079
The increasing prevalence of breast cancer presents a significant global health challenge, highlighting the urgent need for improved diagnostic and treatment monitoring methods. The non-invasive nature of cell-free circulating epigenomic...
3.
Hsieh R, Symonds L, Siu J, Cohen S
Int Rev Cell Mol Biol . 2025 Feb; 391:43-93. PMID: 39939078
The sampling of circulating biomarkers provides an opportunity for non-invasive evaluation and monitoring of cancer activity. In modern day practice, this has typically been in the form of circulating tumor...
4.
Kuttikrishnan S, Prabhu K, Habeeba U, Mariyam Z, Fernandes Q, Maqbool M, et al.
Int Rev Cell Mol Biol . 2025 Feb; 391:223-255. PMID: 39939077
Nectin cell adhesion protein 4 (Nectin-4), a calcium-independent immunoglobulin-like protein, has garnered significant attention in oncology due to its pronounced overexpression in malignant tumors and absence in healthy adult tissues....
5.
Fernandes Q, Ansari A, Makni-Maalej K, Merhi M, Dermime S, Ahmad A, et al.
Int Rev Cell Mol Biol . 2025 Feb; 391:199-222. PMID: 39939076
Multiple myeloma (MM) is a complex hematologic malignancy characterized by the abnormal proliferation of plasma cells in the bone marrow, leading to significant clinical challenges and a high burden of...
6.
Krishnan S, Kanthaje S, Rekha P, Mujeeburahiman M, Ratnacaram C
Int Rev Cell Mol Biol . 2025 Feb; 391:135-197. PMID: 39939075
Renal cell carcinoma (RCC) and Bladder cancer (BC) are two lethal urological cancers that require diagnosis at their earliest stage causing decreasing survival rates in case of aggressive disease. However,...
7.
Stefanes N, Cunha-Silva M, de Oliveira Silva L, Walter L, Santos-Silva M, Gartia M
Int Rev Cell Mol Biol . 2025 Feb; 391:1-41. PMID: 39939074
Cancer presents a significant challenge to global health, driving worldwide concerted efforts to advance early detection, predict therapeutic response, and identify novel targeted therapies. Liquid biopsies emerge as promising avenues...
8.
Galluzzi L, Spada S
Int Rev Cell Mol Biol . 2025 Jan; 390():xiii-xvii. PMID: 39864898
No abstract available.
9.
Kim J, Schanzer N, Singh R, Zaman M, Garcia-Medina J, Proszynski J, et al.
Int Rev Cell Mol Biol . 2025 Jan; 390():67-108. PMID: 39864897
Acute myeloid leukemia (AML) is a complex cancer, yet advances in recent years from integrated genomics methods have helped improve diagnosis, treatment, and means of patient stratification. A recent example...
10.
Figueroa-Angulo E, Puente-Rivera J, Perez-Navarro Y, Condado E, Alvarez-Sanchez M
Int Rev Cell Mol Biol . 2025 Jan; 390():25-66. PMID: 39864896
The critical role of a subset of Human Papillomavirus in cervical cancer has been widely acknowledged and studied. Despite progress in our understanding of the viral molecular mechanisms of pathogenesis,...